Literature DB >> 26671702

Preventing patient absenteeism: validation of a predictive overbooking model.

Mark W Reid, Samuel Cohen, Hank Wang, Aung Kaung, Anish Patel, Vartan Tashjian, Demetrius L Williams, Bibiana Martinez, Brennan M R Spiegel1.   

Abstract

OBJECTIVES: To develop a model that identifies patients at high risk for missing scheduled appointments ("no-shows" and cancellations) and to project the impact of predictive overbooking in a gastrointestinal endoscopy clinic-an exemplar resource-intensive environment with a high no-show rate. STUDY
DESIGN: We retrospectively developed an algorithm that uses electronic health record (EHR) data to identify patients who do not show up to their appointments. Next, we prospectively validated the algorithm at a Veterans Administration healthcare network clinic.
METHODS: We constructed a multivariable logistic regression model that assigned a no-show risk score optimized by receiver operating characteristic curve analysis. Based on these scores, we created a calendar of projected open slots to offer to patients and compared the daily performance of predictive overbooking with fixed overbooking and typical "1 patient, 1 slot" scheduling.
RESULTS: Data from 1392 patients identified several predictors of no-show, including previous absenteeism, comorbid disease burden, and current diagnoses of mood and substance use disorders. The model correctly classified most patients during the development (area under the curve [AUC] = 0.80) and validation phases (AUC = 0.75). Prospective testing in 1197 patients found that predictive overbooking averaged 0.51 unused appointments per day versus 6.18 for typical booking (difference = -5.67; 95% CI, -6.48 to -4.87; P < .0001). Predictive overbooking could have increased service utilization from 62% to 97% of capacity, with only rare clinic overflows.
CONCLUSIONS: Information from EHRs can accurately predict whether patients will no-show. This method can be used to overbook appointments, thereby maximizing service utilization while staying within clinic capacity.

Entities:  

Mesh:

Year:  2015        PMID: 26671702

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  7 in total

1.  Utilization of Census Tract-Based Neighborhood Poverty Rates to Predict Non-adherence to Screening Colonoscopy.

Authors:  Philip Vutien; Rucha Shah; Karen Ma; Nasir Saleem; Joshua Melson
Journal:  Dig Dis Sci       Date:  2019-03-14       Impact factor: 3.199

2.  Predictive overbooking and active recruitment increases uptake of endoscopy appointments among African American patients.

Authors:  Folasade P May; Mark W Reid; Samuel Cohen; Francis Dailey; Brennan M R Spiegel
Journal:  Gastrointest Endosc       Date:  2016-09-10       Impact factor: 9.427

3.  Preventing Endoscopy Clinic No-Shows: Prospective Validation of a Predictive Overbooking Model.

Authors:  Mark W Reid; Folasade P May; Bibiana Martinez; Samuel Cohen; Hank Wang; Demetrius L Williams; Brennan M R Spiegel
Journal:  Am J Gastroenterol       Date:  2016-07-05       Impact factor: 10.864

4.  The Effects of Session Standardization and Template Optimization on Improving Access to High-Demand Pediatric Subspecialty Care.

Authors:  Angela S Volk; Larry H Hollier; Grace N Karon; David E Bank
Journal:  J Ambul Care Manage       Date:  2020 Jan/Mar

5.  Development and validation of a patient no-show predictive model at a primary care setting in Southern Brazil.

Authors:  Henry Lenzi; Ângela Jornada Ben; Airton Tetelbom Stein
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

6.  Recovery of cognitive function after sedation with propofol for outpatient gastrointestinal endoscopy.

Authors:  Sanath Allampati; Sijin Wen; Feiyu Liu; Justin T Kupec
Journal:  Saudi J Gastroenterol       Date:  2019 May-Jun       Impact factor: 2.485

7.  Racial differences in no-show rates for screening mammography.

Authors:  Whitney L Hensing; Steven P Poplack; Cheryl R Herman; Siobhan Sutcliffe; Graham A Colditz; Foluso O Ademuyiwa
Journal:  Cancer       Date:  2021-04-01       Impact factor: 6.921

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.